| Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy. | Food Funct | 2018 Mar 1 | 29485654 |
| Natural plant products inhibits growth and alters the swarming motility, biofilm formation, and expression of virulence genes in enteroaggregative and enterohemorrhagic Escherichia coli. | Food Microbiol | 2016 Oct | 27375253 |
| Effect of antibiotics on cellular stress generated in Shiga toxin-producing Escherichia coli O157:H7 and non-O157 biofilms. | Toxicol In Vitro | 2015 Oct | 26130220 |
| Clostridium difficile colitis: review of the therapeutic approach. | Am J Ther | 2014 Sep-Oct | 22990077 |
| Challenges and opportunities in the management of Clostridium difficile infection. | Expert Rev Gastroenterol Hepatol | 2014 Nov | 25012255 |
| The potential for emerging therapeutic options for Clostridium difficile infection. | Gut Microbes | 2014 | 25564777 |
| Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis. | Clin Ther | 2013 Sep | 23972578 |
| Best strategies in recurrent or persistent Clostridium difficile infection. | Surg Infect (Larchmt) | 2011 Jun | 21767157 |
| Recurrent Clostridium difficile infection: causality and therapeutic approaches. | Int J Antimicrob Agents | 2009 Mar | 19303567 |
| Clostridium difficile: controversies and approaches to management. | Curr Opin Infect Dis | 2009 Dec | 19738464 |